A randomized pilot study in type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone

Diabetic Medicine

Volumn 24, Issue 7, 2007, Pages 778-783

  Thomas, R M ^a   Aldibbiat, A ^b   Griffin, W ^a   Cox, M A A ^c   Leech, N J ^d   Shaw, J A M ^b  

^a Newcastle Diabetes Centre   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Altered hypoglycaemia awareness; CGMS; CSII; Insulin analogue; Severe hypoglycaemia

Indexed keywords

INSULIN GLARGINE; INSULIN LISPRO;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PATIENT EDUCATION; PILOT PROJECTS; PROSPECTIVE STUDIES; RECURRENCE;

EID: 34347337679     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02196.x     Document Type: Article

References (20)

1. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 Type 1 diabetic patients. Diabet Med 1991 8 : 217 222.
2. Frier BM. Epidemiology, short- and long-term consequences of hypoglycaemia. Diabetes Nutr Metab 2002 15 : 378 384.
3. Diabetes Control Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997 46 : 271 286.
4. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F et al. Meticulous prevention of hypoyglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993 42 : 1683 1689.
5. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994 344 : 283 287.
6. Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH. Reduced frequency of severe hypoglycaemia and coma in well-controlled IDDM patients treated with insulin lispro. Diabetes Care 1997 20 : 1827 1832.
7. Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for Type 1 diabetes. Diabetes Care 2000 23 : 639 643.
8. Ashwell SG, Gebbie J, Home PD. Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times. Diabet Med 2006 23 : 46 52.
9. Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia 2004 47 : 622 629.
10. Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA et al. Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes. Diabet Med 2006 23 : 285 292.
11. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care 1996 19 : 324 327.
12. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane VW. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004 27 : 1554 1558.
13. Hirsch IB, Bode BW, Garg S, Lane WS, Sussmann A, Hu P et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005 28 : 533 538.
14. American Diabetes Association Workgroup. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005 28 : 1245 1249.
15. Clarke WL, Cox DJ, Gonder-Frederick LA, Jolian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995 18 : 517 522.
16. Diabetes Control Complications Trial Research Group. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988 11 : 725 732.
17. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of Hypoglycaemia: Quantification, validation, and utilization. Diabetes Care 1987 10 : 617 621.
18. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000 2 : 49 56.
19. Gross TM, Mastrototaro JJ. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2000 2 : S19 26.
20. Albright ES, Desmond R, Bell DS. Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy. Diabetes Care 2004 27 : 632 633.